AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Weekly, daily risedronate equally effective. ('A Reasonable Alternative').
SAN DIEGO -- A 35-mg weekly dose of risedronate is just as effective as a 5-mg daily dose, according to results of a detailed bone study.
The findings suggest that weekly dosing of the agent for postmenopausal women "is a reasonable alternative" to daily dosing, Earl W. Sod, Ph.D., reported in a poster session at the annual meeting of the American Association of Clinical Endocrinologists.
"From a bone safety point of view, the weekly-dose group had results similar to the daily-dose group in general across all parameters. The findings were remarkably close to what we expected for the study."
He added that this is the first study to demonstrate that daily and weekly regimens of risedronate (Actonel) produce similar results at the bone tissue and cellular levels.
The investigators assessed the lumbar spine bone mineral density and obtained iliac crest biopsy specimens in 109 postmenopausal women on risedronate therapy at baseline and at the end of 2 years. The dosing of the 109 patients was as follows: 40 received 5 mg daily; 37 ...
- New Gleevec(R) Data: Prolonged Efficacy with Approved 400 mg Daily Dose and...
- Press release article from: PR Newswire December 6, 2004 700+ words
...Second study shows patients on 800 mg daily achieved greater molecular response than patients on currently recommended 400 mg daily dose -- Patients in both studies were...certain form of leukemia** receiving 400 mg daily maintained their response to therapy long...
- In a New Study Actonel(R) 35 mg Once-a-Week Was as Effective as 5 mg Daily In...
- Press release article from: PR Newswire November 12, 2001 700+ words
...comparable to the 4.0 percent increase achieved with the 5 mg daily dose. Total hip, femoral neck and trochanteric BMD also increased...profile of risedronate 35 mg once a week was comparable to the 5 mg daily dose. The study included postmenopausal women at least 50...
- University of Utah details research in life sciences.
- Newspaper article from: Blood Weekly September 25, 2008 700+ words
...dose was titrated up to 112 mg weekly (16 mg daily) to achieve an INR of 2.5...dosage was decreased to 100 mg daily. Within 2 weeks following that...requirements decreased to 105 mg weekly (15 mg daily). Azathioprine was the probable...
- Once-Weekly Alendronate Tablets.
- Magazine article from: Internal Medicine Alert May 29, 2001 700+ words
...70 mg once weekly showed the same efficacy as 10 mg daily. The mean increases in bone mineral density (BMD...Similarly in a 1-year prevention trial, alendronate 35 mg weekly and 5 mg daily produced a 2.9% (95% CI = 2.6-3.2) and...
- Updates.
- Magazine article from: Infectious Disease Alert November 1, 1999 700+ words
...randomly assigned to receive azithromycin 1200 mg weekly, rifabutin 300 mg daily, or the combination. Patients were followed for...azithromycin group. Administration of azithromycin 1200 mg weekly, in combination with TMP-SMX, is a cost-effective...
- Azithromycin for PCP Prophylaxis.(Pneumocystic carinii pneumonia)
- Magazine article from: Infectious Disease Alert Kember, Carol A. November 1, 1999 700+ words
...randomly assigned to receive azithromycin 1200 mg weekly, rifabutin 300 mg daily, or the combination. Patients were followed for...azithromycin group. Administration of azithromycin 1200 mg weekly, in combination with TMPSMX, is a cost-effective...
- In a New Observational Analysis, Risedronate Significantly Reduced Nonvertebral...
- Press release article from: PR Newswire September 22, 2003 700+ words
...nonvertebral fracture risk in 5,024 patients who began treatment with risedronate (5 mg daily or 30 mg weekly), alendronate (5/10 mg daily or 35/70 mg weekly) or nasal calcitonin (200 I.U. daily), between July 2000 and June 2001. Nonvertebral...
- Observational analysis: Risedronate reduced nonvertebral fracture risk.
- Newspaper article from: Genomics & Genetics Weekly October 31, 2003 700+ words
...nonvertebral fracture risk in 5024 patients who began treatment with risedronate (5 mg daily or 30 mg weekly), alendronate (5/10 mg daily or 35/70 mg weekly), or nasal calcitonin (200 I.U. daily), between July 2000-June 2001. Nonvertebral...
